Add BrightSurf on Google Email

Search results for “Oncology”

1,000+ results for "Oncology"

First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen

A study published in the Journal of Clinical Oncology found that women who underwent chemotherapy with the CMF regimen between 1976 and 1995 scored slightly lower on cognitive tests compared to those without a history of cancer. The differences were subtle but statistically significant, affecting word learning, memory, and information ...

SourceAmerican Society of Clinical Oncology·JournalJournal of Clinical Oncology·DateFeb 27, 2012

First prospective analysis links breast and pancreatic cancer risk with lynch syndrome

A prospective study links Lynch syndrome with significantly increased risks of breast and pancreatic cancers, while relatives without genetic mutations have no increased risk. The study provides clearer estimates of cancer risks associated with Lynch syndrome and may inform screening and early detection strategies.

SourceAmerican Society of Clinical Oncology·JournalJournal of Clinical Oncology·DateFeb 13, 2012

Metabolomx test detects lung cancer from breath

A study published in the Journal of Thoracic Oncology found that a breath test using Metabolomx's colorimetric sensor array can detect lung cancer and differentiate between its types with high accuracy. The test shows promise as a non-invasive, rapid, and inexpensive companion diagnostic for early lung cancer detection.

SourceBurns McClellan·JournalJournal of Thoracic Oncology·DateDec 15, 2011

ASTRO publishes evidence-based guideline for thoracic radiotherapy

The American Society for Radiation Oncology (ASTRO) has developed a guideline for palliative thoracic radiation therapy to treat advanced lung cancer. The guideline recommends various regimens of thoracic external beam radiation therapy as effective for symptom palliation, but not endobronchial brachytherapy or concurrent chemotherapy.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateApr 27, 2011

Soy increases radiation's ability to kill lung cancer cells, study shows

A recent study published in the Journal of Thoracic Oncology found that soy isoflavones can sensitize cancer cells to radiation, increasing killing efficiency while protecting normal lung tissue from damage. Researchers used a soy mixture consisting of genistein, daidzein and glycitein to demonstrate this effect.

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateApr 1, 2011

Teens and young adults with cancer face unique challenges and require targeted care

The article discusses the need for targeted care in adolescents and young adults with cancer, who require collaboration between pediatric and medical oncologists. Research has shown that AYA cancer patients often deal with ongoing developmental and psychosocial issues, making it essential to address these challenges.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Adolescent and Young Adult Oncology·DateMar 14, 2011

Clinical observation leads to lung cancer discovery

A recent study published in the Journal of Thoracic Oncology has revealed that pemetrexed, an established chemotherapy drug, can produce significant responses in patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer. The treatment was found to be effective in over half of these patients, offering n...

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Thoracic Oncology·DateMar 7, 2011

Childhood cancer research in danger

Despite significant improvements in childhood cancer survival rates, research funding is inadequate and collaboration among countries is limited. The report calls for increased EU funding to support a Europe-wide clinical trials network and the creation of a European Childhood Cancer Epidemiological Registry.

SourceECCO-the European CanCer Organisation·Journalecancermedicalscience·DateFeb 8, 2011

Practical Radiation Oncology publishes first issue

The American Society for Radiation Oncology's new journal, Practical Radiation Oncology (PRO), has published its inaugural issue. PRO will provide a forum for radiation oncologists to share information on current practices and advancements in the field. The journal aims to improve the quality of radiation oncology practice through disc...

SourceElsevier·JournalPractical Radiation Oncology·DateJan 25, 2011

Spanish Oncology to establish a new standard treatment on breast cancer at early stages

A Spanish Oncology study has established a new standard treatment for early-stage breast cancer, reducing the risk of recurrence by 32% in women with high-risk but node-negative disease. The treatment, which combines docetaxel with cyclophosphamide, was found to improve disease-free survival and overall quality of life.

SourceGEICAM (Grupo Español de Investigación en Cáncer de Mama)·JournalNew England Journal of Medicine·DateDec 2, 2010

5 awarded ASTRO research grants

The American Society for Radiation Oncology (ASTRO) has selected five physicians as recipients of two grants, the Junior Faculty Career Research Training Award and the Residents/Fellows in Radiation Oncology Research Seed Grant Award. The awards support junior physician faculty and residents/fellows in radiation oncology research.

Results from a study testing methylphenidate for cancer-related fatigue

Researchers tested methylphenidate, a psychostimulant medication, to treat cancer-related fatigue. While the study found no significant difference between treatment and placebo groups, there was a trend of improved satisfaction with treatment among patients receiving methylphenidate, particularly those with stage III/IV cancer.

SourceMayo Clinic·JournalJournal of Clinical Oncology·DateJun 2, 2010

Study identifies promising treatment for aggressive lymphoma

A study published in the American Society of Clinical Oncology annual meeting showed that lenalidomide significantly improved response rates and complete remission in patients with transformed lymphoma. Patients treated with lenalidomide had a remarkable response rate, with some experiencing complete remission for over a year.

SourceMayo Clinic·JournalJournal of Clinical Oncology·DateMay 26, 2010